Sunfish Part 2: 24-Month Efficacy And Safety Of Risdiplam In Patients With Type 2 Or Non-Ambulant Type 3 Sma

EUROPEAN JOURNAL OF NEUROLOGY(2021)

引用 3|浏览23
暂无评分
关键词
risdiplam,sunfish part,non-ambulant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要